MDGL · Madrigal Pharmaceuticals Inc

-

-

Please sign in to comment on MDGL

1 Comment

Admin
4 years ago

Madrigal Pharmaceuticals, Inc is currently in a long term downtrend where the price is trading 14.2% below its 200 day moving average.

From a valuation standpoint, the stock is 100.0% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.0.

Madrigal Pharmaceuticals, Inc's total revenue sank by nan% to $0 since the same quarter in the previous year.

Its net income has dropped by 113.1% to $-59M since the same quarter in the previous year.

Finally, its free cash flow fell by 342.6% to $-55M since the same quarter in the previous year.

Based on the above factors, Madrigal Pharmaceuticals, Inc gets an overall score of 1/5.












© PyInvesting 2025

About    Blog    Influencers   Careers   Contact Us   Disclaimer   Privacy Policy